Page 1 | Search Results | Blood | American Society of Hematology

1-18 of 18

Sort by

Sort Order Select

Journal Articles

Allogeneic Hematopoietic Stem Cell Transplantation for Patients with Aggressive Natural Killer Cell Leukemia: An Advantage of Cord Blood Transplantation

Ayumi Fujimoto, MD, Fumihiro Ishida, MD PhD, Koji Izutsu, MD PhD, Satoshi Yamasaki, MD PhD, Dai Chihara, MD PhD, Junji Suzumiya, MD PhD, Tetsuo Mitsui, MD PhD, Kazuteru Ohashi, MD PhD, Hideyuki Nakazawa, MD PhD, Hikaru Kobayashi, MD PhD, Junya Kanda, MD, Takahiro Fukuda, Yoshiko Atsuta, MD PhD, Ritsuro Suzuki, MD PhD

Blood (2019) 134 (Supplement_1): 2032.

https://doi.org/10.1182/blood-2019-122049

Published: 2019

Journal Articles

STAT3 Mutations and Anemia with Pure Red Cell Aplasia Are the Distinctive Features of T Cell Receptor Gamma Delta Type Large Granular Lymphocyte Leukemia

Taku Yamane, Toru Kawakami, MD, Nodoka Sekiguchi, MD PhD, Jun Kobayashi, Toshimitsu Ueki, MD, Hikaru Kobayashi, MD PhD, Sayaka Nishina, Kaoko Sakai, MD, Hitoshi Sakai, MD, Kazuo Oshimi, MD, Yumiko Higuchi, PhD, Hideyuki Nakazawa, MD PhD, Fumihiro Ishida, MD PhD

Blood (2019) 134 (Supplement_1): 1500.

https://doi.org/10.1182/blood-2019-123614

Published: 2019

Journal Articles

Somatic Mutations of Myeloid Malignancy-Associated Genes in Acquired Pure Red Cell Aplasia in Adults

Makoto Hirokawa, MD PhD, Junki Kohmaru, Souichi Koyota, PhD, Keiji Kuba, MD, Naohito Fujishima, MD, Tomoo Saga, MD, Ayumi Omokawa, MD, Shigeharu Ueki, MD, Fumihiro Ishida, MD FACP, Shinji Nakao, MD PhD, Akira Matsuda, MD, Akiko Ohta, MD, Kaoru Tohyama, MD, Ryuji Suzuki, DVM, PhD, Kinuko Mitani, MD

Blood (2018) 132 (Supplement 1): 3858.

https://doi.org/10.1182/blood-2018-99-113262

Published: 2018

Journal Articles

Frequent STAT3 Mutations in CD8 + T Cells from Patients with Pure Red Cell Aplasia

Toru Kawakami, MD, Nodoka Sekiguchi, MD PhD, Jun Kobayashi, Tatsuya Imi, MD, Kazuyuki Matsuda, PhD, Taku Yamane, Sayaka Nishina, MD, Yasushi Senoo, MD, Hitoshi Sakai, MD PhD, Toshiro Ito, MD PhD, Tomonobu Koizumi, MD PhD, Makoto Hirokawa, MD PhD, Shinji Nakao, MD PhD, Hideyuki Nakazawa, PhD MD, Fumihiro Ishida, MD FACP

Blood (2018) 132 (Supplement 1): 536.

https://doi.org/10.1182/blood-2018-99-112132

Published: 2018

Journal Articles

Recurrent STAT3 Mutations in the Lymphocytes of Pure Red Cell Aplasia without T-Cell Large Granular Lymphocytic Leukemia

Toru Kawakami, MD, Nodoka Sekiguchi, MD, Toshiya Otsuka, Tatsuya Imi, MD, Sayaka Nishina, MD, Noriko Senoo, MD, Yasushi Senoo, MD, Hitoshi Sakai, MD, Toshiro Ito, MD PhD, Tomonobu Koizumi, MD PhD, Shinji Nakao, MD PhD, Hideyuki Nakazawa, MD PhD, Fumihiro Ishida, MD PhD

Blood (2017) 130 (Supplement 1): 1181.

https://doi.org/10.1182/blood.V130.Suppl_1.1181.1181

Published: 2017

Journal Articles

Mutational Landscape of Aggressive Natural Killer Cell Leukemia and Drug Sensitivity Profiling Reveal Therapeutic Options in Natural Killer Cell Malignancies

Blood (2016) 128 (22): 2921.

https://doi.org/10.1182/blood.V128.22.2921.2921

Published: 2016

Journal Articles

Screening Method for Hepatic Fibrinogen Storage Disease Associated with Congenital Hypofibrinogenemia

Shinpei Arai, MS, Saki Mukai, BA, Yuka Takezawa, PhD, Mitsutoshi Sugano, PhD, Takayuki Honda, MD PhD, Fumihiro Ishida, MD PhD, Nobuo Okumura, PhD

Blood (2015) 126 (23): 3504.

https://doi.org/10.1182/blood.V126.23.3504.3504

Published: 2015

Journal Articles

Exome Sequencing of Aggressive Natural Killer Cell Leukemia and Drug Profiling Highlight Candidate Driver Pathways in Malignant Natural Killer Cells

Blood (2015) 126 (23): 700.

https://doi.org/10.1182/blood.V126.23.700.700

Published: 2015

Journal Articles

STAT5b Gene Mutations and Their Association with a Unique Immunophenotype of CD4+CD56+TCRαβ Type LGL Leukemia

Takahiro Tanahashi, Kazuyuki Matsuda, PhD, Nodoka Sekiguchi, MD PhD, Sayaka Nishina, MD, Noriko Senoo, MD, Kaoko Sakai, Hitoshi Sakai, MD, Toshiro Ito, MD PhD, Takeki Mitsui, MD, PhD, Yok Lam Kwong, MD, Fumihiro Ishida, MD PhD

Blood (2014) 124 (21): 1652.

https://doi.org/10.1182/blood.V124.21.1652.1652

Published: 2014

Journal Articles

STAT3 Gene Mutations and the Association with Pure Red Cell Aplasia in Large Granular Lymphocyte Leukemia.

Nodoka Sekiguchi, MD, Kazuyuki Matsuda, PhD, Kayoko Momose, MD, Hideki Makishima, MD, PhD, Toshiro Ito, MD, Fumihiro Ishida, MD

Blood (2012) 120 (21): 2668.

https://doi.org/10.1182/blood.V120.21.2668.2668

Published: 2012

Journal Articles

Expression of CD56 Is an Independent Prognostic Factor to Predict Relapse in Acute Myeloid Leukemia with t(8;21): Results of Japan Adult Leukemia Study Group (JALSG) AML97 Protocol.

Noriyoshi Iriyama, Yoshihiro Hatta, MD, PhD, Jin Takeuchi, MD, PhD, Yoshiaki Ogawa, MD, PhD, Shigeki Ohtake, MD, PhD, Toru Sakura, MD, PhD, Kinuko Mitani, MD, Fumihiro Ishida, MD, Masatomo Takahashi, MD, Tomoya Maeda, MD, PhD, Tohru Izumi, MD, Hisashi Sakamaki, MD, Shuichi Miyawaki, MD, Sumihisa Honda, PhD, Yasushi Miyazaki, MD, PhD, Tomohiko Taki, MD, PhD, Masafumi Taniwaki, MD, PhD, Tomoki Naoe, MD, PhD

Blood (2012) 120 (21): 2511.

https://doi.org/10.1182/blood.V120.21.2511.2511

Published: 2012

Journal Articles

Pretreatment EBV-DNA Copy Number Is Predictive for Response to SMILE Chemotherapy for Newly-Diagnosed Stage IV, Relapsed or Refractory Extranodal NK/T-Cell Lymphoma, Nasal Type: Results of NKTSG Phase II Study

Ritsuro Suzuki, MD, PhD, Hiroshi Kimura, MD, Yok-Lam Kwong, Yoshinobu Maeda, Chizuko Hashimoto, MD, Won Seog Kim, Cheolwon Suh, MD, Koji Izutsu, MD, PhD, Fumihiro Ishida, MD, Yoshinori Ito, Motoko Yamaguchi, MD, PhD, Junji Suzumiya, MD, Rie Hyo, Shigeo Nakamura, MD, Kazuo Oshimi, MD

Blood (2010) 116 (21): 2873.

https://doi.org/10.1182/blood.V116.21.2873.2873

Published: 2010

Journal Articles

Aggressive NK Cell Leukemia (ANKL): Experience with 34 Patients and Therapeutic Potentials of L-Asparaginase and Allogeneic Hematopoietic Cell Transplantation - A Japan-Korea Multicenter Study for ANKL (ANKL07) -

Fumihiro Ishida, MD, Won Seog Kim, MD, Young Hyeh Ko, MD, Junji Suzumiya, MD, Yasushi Isobe, MD, Kazuo Oshimi, MD, Shigeo Nakamura, MD, Ritsuro Suzuki, MD, PhD

Blood (2010) 116 (21): 3091.

https://doi.org/10.1182/blood.V116.21.3091.3091

Published: 2010

Journal Articles

Profiles of Cytotoxic Molecules In Mature NK Cell Neoplasms

Nodoka Sekiguchi, MD, Naoko Asano, MD, Hideki Makishima, MD, PhD, Masanobu Momose, MT, Toshiro Ito, MD, Shigeo Nakamura, MD, Fumihiro Ishida, MD

Blood (2010) 116 (21): 4140.

https://doi.org/10.1182/blood.V116.21.4140.4140

Published: 2010

Journal Articles

Phase 2 Study of FLAGM (Fludarabine+High-Dose Ara-C +G-CSF+Mitoxantrone) for Relapsed or Refractory Acute Myeloid Leukemia (AML): A Report From the Japan Adult Leukemia Study Group (JALSG).

Shuichi Miyawaki, MD, PhD, Naoko Hatsumi, MD, Takahiro Yamauchi, MD, Kousuke Tsuboi, MD, Atsushi Fujieda, MD, Akihiro Takeshita, MD, Norio Komatsu, MD, Noriko Usui, MD, Yukihiro Arai, MD, Fumihiro Ishida, MD, PhD, Takeshi Morii, MD, Yasuhiko Kano, MD, Michinori Ogura, MD, PhD, Noriko Doki, MD, Kazunori Ohnishi, MD, Tomoki Naoe, MD, Ryuzo Ohno, MD

Blood (2009) 114 (22): 1058.

https://doi.org/10.1182/blood.V114.22.1058.1058

Published: 2009

Journal Articles

Cytotoxic Molecule (CM)-Positive Classical Hodgkin Lymphoma: a Clinicopathologic Study in Comparison with Nodal Peripheral T-Cell Lymphoma of Not Otherwise Specified Type Possessing CM Expression.

Naoko Asano, MD, PhD, Jun-Ichi Tamaru, MD, PhD, Fumihiro Ishida, MD, PhD, Tadashi Yoshino, MD, PhD, Yoshitoyo Kagami, MD, PhD, Yasuo Morishima, MD, PhD, Masao Seto, MD, PhD, Tomohiro Kinoshita, MD, PhD, Shigeo Nakamura, MD, PhD

Blood (2009) 114 (22): 1549.

https://doi.org/10.1182/blood.V114.22.1549.1549

Published: 2009

Journal Articles

Age-Related EBV-Associated B-Cell Lymphoproliferative Disorders: Comparison with EBV-Positive Classical Hodgkin Lymphoma in Elderly Patients

Naoko Asano, MD, Kazuhito Yamamoto, MD, Jun-Ichi Tamaru, MD, Takashi Oyama, MD, Fumihiro Ishida, MD, Koichi Ohshima, MD, Tadashi Yoshino, MD, Naoya Nakamura, MD, Shigeo Mori, MD, Osamu Yoshie, MD, Yoshie Shimoyama, MD, Yasuo Morishima, Tomohiro Kinoshita, MD, Shigeo Nakamura, MD

Blood (2008) 112 (11): 5282.

https://doi.org/10.1182/blood.V112.11.5282.5282

Published: 2008

Journal Articles

Role of NOTCH1 in Aggressive NK-Cell Leukemia.

Hideki Makishima, MD, PhD, Masao Ota, PhD, Takefumi Suzuki, Kozo Nakayama, PhD, Fumihiro Ishida, MD, PhD

Blood (2007) 110 (11): 4231.

https://doi.org/10.1182/blood.V110.11.4231.4231

Published: 2007

NARROW

Allogeneic Hematopoietic Stem Cell Transplantation for Patients with Aggressive Natural Killer Cell Leukemia: An Advantage of Cord Blood Transplantation

STAT3 Mutations and Anemia with Pure Red Cell Aplasia Are the Distinctive Features of T Cell Receptor Gamma Delta Type Large Granular Lymphocyte Leukemia

Somatic Mutations of Myeloid Malignancy-Associated Genes in Acquired Pure Red Cell Aplasia in Adults

Frequent STAT3 Mutations in CD8 + T Cells from Patients with Pure Red Cell Aplasia

Recurrent STAT3 Mutations in the Lymphocytes of Pure Red Cell Aplasia without T-Cell Large Granular Lymphocytic Leukemia

Mutational Landscape of Aggressive Natural Killer Cell Leukemia and Drug Sensitivity Profiling Reveal Therapeutic Options in Natural Killer Cell Malignancies

Screening Method for Hepatic Fibrinogen Storage Disease Associated with Congenital Hypofibrinogenemia

Exome Sequencing of Aggressive Natural Killer Cell Leukemia and Drug Profiling Highlight Candidate Driver Pathways in Malignant Natural Killer Cells

STAT5b Gene Mutations and Their Association with a Unique Immunophenotype of CD4+CD56+TCRαβ Type LGL Leukemia

STAT3 Gene Mutations and the Association with Pure Red Cell Aplasia in Large Granular Lymphocyte Leukemia.

Expression of CD56 Is an Independent Prognostic Factor to Predict Relapse in Acute Myeloid Leukemia with t(8;21): Results of Japan Adult Leukemia Study Group (JALSG) AML97 Protocol.

Pretreatment EBV-DNA Copy Number Is Predictive for Response to SMILE Chemotherapy for Newly-Diagnosed Stage IV, Relapsed or Refractory Extranodal NK/T-Cell Lymphoma, Nasal Type: Results of NKTSG Phase II Study

Aggressive NK Cell Leukemia (ANKL): Experience with 34 Patients and Therapeutic Potentials of L-Asparaginase and Allogeneic Hematopoietic Cell Transplantation - A Japan-Korea Multicenter Study for ANKL (ANKL07) -

Profiles of Cytotoxic Molecules In Mature NK Cell Neoplasms

Phase 2 Study of FLAGM (Fludarabine+High-Dose Ara-C +G-CSF+Mitoxantrone) for Relapsed or Refractory Acute Myeloid Leukemia (AML): A Report From the Japan Adult Leukemia Study Group (JALSG).

Cytotoxic Molecule (CM)-Positive Classical Hodgkin Lymphoma: a Clinicopathologic Study in Comparison with Nodal Peripheral T-Cell Lymphoma of Not Otherwise Specified Type Possessing CM Expression.

Age-Related EBV-Associated B-Cell Lymphoproliferative Disorders: Comparison with EBV-Positive Classical Hodgkin Lymphoma in Elderly Patients

Role of NOTCH1 in Aggressive NK-Cell Leukemia.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only